• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

预测急性心力衰竭患者心脏恶化至心源性休克。

Prediction of cardiac worsening through to cardiogenic shock in patients with acute heart failure.

机构信息

Department of Cardiology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.

German Centre for Cardiovascular Research (DZHK), Partner Site Hamburg/Lübeck/Kiel, Hamburg, Germany.

出版信息

ESC Heart Fail. 2024 Aug;11(4):2249-2258. doi: 10.1002/ehf2.14792. Epub 2024 Apr 17.

DOI:10.1002/ehf2.14792
PMID:38632837
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11287305/
Abstract

AIMS

Acute heart failure (AHF) can result in worsening of heart failure (WHF), cardiogenic shock (CS), or death. Risk factors for these adverse outcomes are not well characterized. This study aimed to identify predictors for WHF or new-onset CS in patients hospitalized for AHF.

METHODS AND RESULTS

Prospective cohort study enrolling consecutive patients with AHF admitted to a large tertiary care centre with follow-up until death or discharge. WHF was defined by the RELAX-AHF-2 criteria. CS was defined as SCAI stages B-E. Potential predictors were assessed by fitting logistic regression models adjusted for age and sex. N = 233 patients were enrolled, median age was 78 years, and 80 were women (35.9%). Ischaemic cardiomyopathy was present in 82 patients (40.8%). Overall, 96 (44.2%) developed WHF and 18 (9.7%) CS. In-hospital death (8/223, 3.6%) was related to both events (WHF: OR 6.64, 95% CI 1.21-36.55, P = 0.03; CS: OR 38.27, 95% CI 6.32-231.81, P < 0.001). Chronic kidney disease (OR 2.20, 95% CI 1.25-3.93, P = 0.007), logarithmized serum creatinine (OR 2.90, 95% CI 1.51-5.82, P = 0.002), cystatin c (OR 1.86, 95% CI 1.27-2.77, P = 0.002), tricuspid valve regurgitation (OR 2.08, 95% CI 1.11-3.94, P = 0.023) and logarithmized pro-adrenomedullin (OR 3.01, 95% CI 1.75-5.38, P < 0.001) were significant predictors of WHF. Chronic kidney disease (OR 3.17, 95% CI 1.16-9.58, P = 0.03), cystatin c (OR 1.88, 95% CI 1.00-3.53, P = 0.045), logarithmized pro-adrenomedullin (OR 2.90, 95% CI 1.19-7.19, P = 0.019), and tricuspid valve regurgitation (OR 10.44, 95% CI 2.61-70.00, P = 0.003) were significantly with new-onset CS.

CONCLUSIONS

Half of patients admitted with AHF experience WHF or new-onset CS. Chronic kidney disease, tricuspid valve regurgitation, and elevated pro-adrenomedullin concentrations predict these events. They could potentially serve as early warning signs for further deterioration in AHF patients.

摘要

目的

急性心力衰竭(AHF)可导致心力衰竭恶化(WHF)、心源性休克(CS)或死亡。这些不良结局的风险因素尚未得到很好的描述。本研究旨在确定因 AHF 住院患者发生 WHF 或新发 CS 的预测因素。

方法和结果

前瞻性队列研究纳入了连续入住大型三级护理中心的 AHF 患者,并进行随访,直至死亡或出院。WHF 采用 RELAX-AHF-2 标准定义。CS 定义为 SCAI 分期 B-E。通过拟合调整年龄和性别的逻辑回归模型评估潜在预测因素。共纳入 233 例患者,中位年龄为 78 岁,80 例女性(35.9%)。82 例(40.8%)存在缺血性心肌病。总体而言,96 例(44.2%)发生 WHF,18 例(9.7%)发生 CS。院内死亡(8/223,3.6%)与这两个事件有关(WHF:OR 6.64,95%CI 1.21-36.55,P=0.03;CS:OR 38.27,95%CI 6.32-231.81,P<0.001)。慢性肾脏病(OR 2.20,95%CI 1.25-3.93,P=0.007)、血清肌酐对数(OR 2.90,95%CI 1.51-5.82,P=0.002)、胱抑素 C(OR 1.86,95%CI 1.27-2.77,P=0.002)、三尖瓣反流(OR 2.08,95%CI 1.11-3.94,P=0.023)和前肾上腺髓质素对数(OR 3.01,95%CI 1.75-5.38,P<0.001)是 WHF 的显著预测因素。慢性肾脏病(OR 3.17,95%CI 1.16-9.58,P=0.03)、胱抑素 C(OR 1.88,95%CI 1.00-3.53,P=0.045)、前肾上腺髓质素对数(OR 2.90,95%CI 1.19-7.19,P=0.019)和三尖瓣反流(OR 10.44,95%CI 2.61-70.00,P=0.003)与新发 CS 显著相关。

结论

一半因 AHF 住院的患者会出现 WHF 或新发 CS。慢性肾脏病、三尖瓣反流和前肾上腺髓质素浓度升高可预测这些事件。它们可能成为 AHF 患者病情进一步恶化的早期预警信号。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f11e/11287305/244e9ef65fab/EHF2-11-2249-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f11e/11287305/40af92ff9a3a/EHF2-11-2249-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f11e/11287305/1a274ec97fb3/EHF2-11-2249-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f11e/11287305/244e9ef65fab/EHF2-11-2249-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f11e/11287305/40af92ff9a3a/EHF2-11-2249-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f11e/11287305/1a274ec97fb3/EHF2-11-2249-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f11e/11287305/244e9ef65fab/EHF2-11-2249-g003.jpg

相似文献

1
Prediction of cardiac worsening through to cardiogenic shock in patients with acute heart failure.预测急性心力衰竭患者心脏恶化至心源性休克。
ESC Heart Fail. 2024 Aug;11(4):2249-2258. doi: 10.1002/ehf2.14792. Epub 2024 Apr 17.
2
Worsening heart failure in 'real-world' clinical practice: predictors and prognostic impact.真实世界临床实践中心力衰竭恶化:预测因素及预后影响。
Eur J Heart Fail. 2017 Aug;19(8):987-995. doi: 10.1002/ejhf.515. Epub 2016 Apr 12.
3
Early worsening heart failure in patients admitted for acute heart failure: time course, hemodynamic predictors, and outcome.急性心力衰竭患者住院期间早期心力衰竭恶化:时间过程、血流动力学预测因素和结局。
J Card Fail. 2009 Oct;15(8):639-44. doi: 10.1016/j.cardfail.2009.04.001. Epub 2009 Jun 13.
4
Early worsening heart failure in patients admitted with acute heart failure--a new outcome measure associated with long-term prognosis?急性心力衰竭患者入院后早期心力衰竭恶化——与长期预后相关的新结局指标?
Fundam Clin Pharmacol. 2009 Oct;23(5):633-9. doi: 10.1111/j.1472-8206.2009.00697.x. Epub 2009 Jul 28.
5
Worsening Heart Failure Following Admission for Acute Heart Failure: A Pooled Analysis of the PROTECT and RELAX-AHF Studies.急性心力衰竭住院后心力衰竭恶化:PROTECT 和 RELAX-AHF 研究的汇总分析。
JACC Heart Fail. 2015 May;3(5):395-403. doi: 10.1016/j.jchf.2015.01.007.
6
In-hospital worsening heart failure in patients admitted for acute heart failure.因急性心力衰竭入院患者的院内心力衰竭恶化
Int J Cardiol. 2016 Dec 15;225:353-361. doi: 10.1016/j.ijcard.2016.10.002. Epub 2016 Oct 5.
7
Outcome of patients with cardiac amyloidosis admitted to an intensive care unit for acute heart failure.因急性心力衰竭住进重症监护病房的心脏淀粉样变性患者的转归。
Arch Cardiovasc Dis. 2018 Oct;111(10):582-590. doi: 10.1016/j.acvd.2018.03.004. Epub 2018 Apr 27.
8
Worsening heart failure, a critical event during hospital admission for acute heart failure: results from the VERITAS study.因急性心力衰竭住院期间的关键事件:心力衰竭恶化,来自 VERITAS 研究的结果。
Eur J Heart Fail. 2014 Dec;16(12):1362-71. doi: 10.1002/ejhf.186. Epub 2014 Nov 5.
9
Characteristics and Outcome of Acute Heart Failure in Infective Endocarditis: Focus on Cardiogenic Shock.感染性心内膜炎中急性心力衰竭的特征和转归:以心原性休克为重点。
Clin Infect Dis. 2021 Sep 7;73(5):765-774. doi: 10.1093/cid/ciab098.
10
In-hospital and long-term outcomes of cardiogenic shock complicating myocardial infarction versus heart failure.心肌梗死后并发心原性休克与心力衰竭的院内和长期结局。
Eur J Heart Fail. 2024 Jul;26(7):1594-1603. doi: 10.1002/ejhf.3333. Epub 2024 Jun 10.

引用本文的文献

1
Pro-adrenomedullin as an independent predictive biomarker for heart failure in atrial fibrillation and flutter.前肾上腺髓质素作为心房颤动和心房扑动中心力衰竭的独立预测生物标志物。
ESC Heart Fail. 2025 Jun;12(3):1893-1904. doi: 10.1002/ehf2.15196. Epub 2025 Jan 13.
2
The Role of Adrenomedullin as a Predictive Marker of the Risk of Death and Adverse Clinical Events: A Review of the Literature.肾上腺髓质素作为死亡风险和不良临床事件预测标志物的作用:文献综述
J Clin Med. 2024 Aug 16;13(16):4847. doi: 10.3390/jcm13164847.

本文引用的文献

1
Transcatheter Repair for Patients with Tricuspid Regurgitation.经导管三尖瓣反流修复术治疗患者。
N Engl J Med. 2023 May 18;388(20):1833-1842. doi: 10.1056/NEJMoa2300525. Epub 2023 Mar 4.
2
Worsening Heart Failure: Nomenclature, Epidemiology, and Future Directions: JACC Review Topic of the Week.心力衰竭恶化:命名、流行病学及未来方向:美国心脏病学会杂志本周综述主题
J Am Coll Cardiol. 2023 Jan 31;81(4):413-424. doi: 10.1016/j.jacc.2022.11.023.
3
Albuminuria as a marker of systemic congestion in patients with heart failure.尿白蛋白作为心力衰竭患者全身淤血的标志物。
Eur Heart J. 2023 Feb 1;44(5):368-380. doi: 10.1093/eurheartj/ehac528.
4
Congestion in heart failure: a circulating biomarker-based perspective. A review from the Biomarkers Working Group of the Heart Failure Association, European Society of Cardiology.心力衰竭中的充血:基于循环生物标志物的观点。来自心力衰竭协会、欧洲心脏病学会的生物标志物工作组的综述。
Eur J Heart Fail. 2022 Oct;24(10):1751-1766. doi: 10.1002/ejhf.2664. Epub 2022 Sep 7.
5
2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure.2021年欧洲心脏病学会急性和慢性心力衰竭诊断与治疗指南。
Eur Heart J. 2021 Sep 21;42(36):3599-3726. doi: 10.1093/eurheartj/ehab368.
6
Acute Kidney Injury in Cardiogenic Shock: An Updated Narrative Review.心源性休克中的急性肾损伤:最新叙述性综述
J Cardiovasc Dev Dis. 2021 Jul 28;8(8):88. doi: 10.3390/jcdd8080088.
7
Activity of the adrenomedullin system to personalise post-discharge diuretic treatment in acute heart failure.去甲肾上腺素能系统活性与急性心力衰竭出院后利尿剂治疗的个体化。
Clin Res Cardiol. 2022 Jun;111(6):627-637. doi: 10.1007/s00392-021-01909-9. Epub 2021 Jul 23.
8
Eligibility for mechanical circulatory support devices based on current and past randomised cardiogenic shock trials.基于当前和既往随机化心源性休克试验的机械循环支持装置的适用标准。
Eur J Heart Fail. 2021 Nov;23(11):1942-1951. doi: 10.1002/ejhf.2274. Epub 2021 Aug 16.
9
Pathophysiology of cardiogenic shock.心源性休克的病理生理学。
Curr Opin Crit Care. 2021 Aug 1;27(4):409-415. doi: 10.1097/MCC.0000000000000853.
10
Temporal trends in incidence, causes, use of mechanical circulatory support and mortality in cardiogenic shock.心源性休克的发病率、病因、机械循环支持的使用及死亡率的时间趋势
ESC Heart Fail. 2021 Apr;8(2):1295-1303. doi: 10.1002/ehf2.13202. Epub 2021 Feb 19.